Section Arrow
Quote
CTSO.NASDAQ
- Cytosorbents Corp
Quotes are at least 15-min delayed:2025/01/21 05:31 EST
Last
 1.03
-0.01 (-0.96%)
Day High 
1.0396 
Prev. Close
1.04 
1-M High
1.145 
Volume 
56.90K 
Bid
0.92
Ask
1.04
Day Low
1.01 
Open
1.01 
1-M Low
0.8024 
Market Cap 
57.15M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1 
20-SMA 0.94 
50-SMA 0.92 
52-W High 1.582109 
52-W Low 0.696526 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.36/-0.06
Enterprise Value
72.59M
Balance Sheet
Book Value Per Share
0.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.08M
Operating Revenue Per Share
0.55
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:31 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.